SHC

Sotera Health Company

Price

$18.28

return (12m)

14.61%

p/e

31.95

p/bv

7.85

DIVIDEND YIELD

0.00%

SHC price

Sotera Health

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SHC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-3.74%

3 months

2.21%

1 year

14.61%

2 years

17.33%

5 years

-29.15%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals SHC

Valuation

P/E

31.95

Sector 1.27

Industry 8.57

P/BV

7.85

Sector 1.88

Industry 3.63

P/Revenue (PSR)

4.30

Sector 1.56

Industry 3.09

EV/EBITDA

47.94

Sector -46.85

Industry -17.98

EV/EBIT

62.18

Sector -51.35

Industry -94.21

P/EBITDA

9.81

Sector -31.66

Industry 7.07

P/EBIT

12.82

Sector -43.19

Industry -32.11

P/Total Assets

1.58

Sector 0.87

Industry 1.32

P/Net Current Assets

-2.62

Sector -26.04

Industry -3.44

P/Working Capital

12.58

Sector -4.00

Industry 7.65

EPS

0.57

Sector -0.70

Industry -0.23

BVPS

2.33

Sector 4.48

Industry 8.61

Efficiency

Gross Margin

54.97%

Sector 49.44%

Industry 55.16%

EBITDA Margin

45.38%

Sector -282.02%

Industry -13.47%

EBIT Margin

34.99%

Sector -164.03%

Industry -25.89%

Operating Margin

21.20%

Sector -19.60%

Industry -5.67%

Net Profit Margins

13.44%

Sector -23.82%

Industry -7.67%

Asset Turnover

0.10

Sector 0.13

Industry 0.13

Profitability

ROE

24.56%

Sector -23.80%

Industry -24.00%

ROA

4.94%

Sector -24.22%

Industry -5.96%

ROIC

10.52%

Sector -587.47%

Industry -21.90%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

2.80

Sector 1.90

Industry 2.56

Net Debt / EBITDA

12.13

Sector -23.34

Industry 9.41

Net Debt / EBIT

15.73

Sector -11.26

Industry -2.82

Net Debt / Equity

2.66

Sector -0.63

Industry -0.19

Gross Debt / Equity

3.19

Sector -0.73

Industry 0.42

Equity/Assets

0.20

Sector 0.46

Industry 0.50

Liabilities/Assets

0.80

Sector 0.50

Industry 0.53

Growth

5Y Revenue CAGR

5.48%

Sector -

Industry -

5Y Earnings CAGR

6.94%

Sector -

Industry -

Fundamentals SHC

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Sotera Health ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$18.28

Fair Value

$5.47

Upside

-70.10%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SHC Sotera Health Company	$18.28	12.91%	0.00%	31.95	7.85	24.56%	13.44%
TMO Thermo Fisher Scientific Inc.	$652.02	23.39%	0.28%	34.69	4.59	13.22%	15.04%
DHR Danaher Corporation	$214.26	2.81%	0.67%	37.74	2.87	7.61%	15.95%
WAT Waters Corporation	$425.14	32.06%	0.00%	251.30	2.75	1.09%	3.58%
IQV IQVIA Holdings Inc.	$257.59	26.40%	0.00%	31.12	6.79	21.82%	8.10%
CGEN Compugen Ltd.	$2.35	46.56%	0.00%	8.06	2.50	31.01%	36.12%
SYNH Syneos Health Inc.	$0.00	-	0.00%	62.97	1.28	2.04%	1.31%
JNJ Johnson & Johnson	$255.81	40.61%	2.06%	29.27	7.25	24.76%	21.48%
LLY Eli Lilly and Compay	$1,139.27	38.90%	0.59%	38.06	30.01	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$395.40	-9.73%	0.00%	44.62	7.65	17.15%	28.44%
SNY Sanofi	$39.70	-17.07%	4.45%	3.72	0.69	18.43%	14.25%
NVS Novartis AG	$140.03	8.37%	2.22%	20.91	6.36	30.41%	23.29%
ABT Abbott Laboratories	$96.56	-25.26%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$86.94	-4.56%	3.30%	21.10	2.17	10.29%	13.93%
GSK GlaxoSmithKline PLC	$46.95	7.91%	3.77%	14.44	4.08	28.24%	14.54%
CVS CVS Health Corporation	$86.67	17.21%	3.09%	22.49	1.38	6.12%	1.18%
BSX Boston Scientific Corp.	$42.80	-55.35%	0.00%	17.31	2.55	14.73%	17.49%
TMDX TransMedics Group Inc.	$77.58	-32.47%	0.00%	17.68	5.18	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$520.16	-16.12%	0.00%	36.04	25.47	70.67%	25.03%
RMD ResMed Inc.	$220.18	-17.85%	1.12%	20.92	4.84	23.13%	26.94%
HCA HCA Healthcare Inc.	$428.58	1.07%	0.71%	13.82	-29.45	-213.15%	8.77%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SHC - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Sotera Health

Sotera Health Company

Average Investor10 user rating

4.0 (3 people)

United States

11 years

Founded: 2015

2020

Time since IPO - 6 years

3.000

Employees

Sotera Health Company (United States) is listed on the Nasdaq and has a market capitalization of $5.22 billion, with shareholders equity totaling $665.65 million.

The company employs approximately 3.000 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, Sotera Health Company reported $1.22 billion in revenue, generating net income of $163.48 million.

Key financial metrics include a P/E ratio of 31.95, a price-to-book (P/B) ratio of 7.85, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SHC.

Market cap

$5.22 billion

Net worth

$665.65 million

$665,648,000.00

Assets

$3.31 billion

$3,306,790,000.00

Total Shares Outstanding

285.77 million

285,773,000

Average Daily Trading Volume

$2.43 million

$2,426,044.62

Sector

Health

Industry

Life Science Tools and Services

SHC

SHC revenue and profits

Financial Results SHC

DRAG THE FRAME TO SEE MORE DATA

SHC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$86.67 15,38% (12M)

P/E

22.49

3.09%

ROE

6.12%

P/BV

1.38

CI - Cigna

$267.68 --11,99% (12M)

P/E

10.33

2.31%

ROE

16.04%

P/BV

1.66

CNC - Centene

$62.50 61,49% (12M)

P/E

-6.05

0.00%

ROE

-22.53%

P/BV

1.36

HUM - Humana

$383.17 37,00% (12M)

P/E

35.89

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$39.70 --18,93% (12M)

P/E

3.72

4.45%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$255.81 38,68% (12M)

P/E

29.27

2.06%

ROE

24.76%

P/BV

7.25

LLY - Eli Lilly

$1,139.27 36,51% (12M)

P/E

38.06

0.59%

ROE

78.84%

P/BV

30.01

HCA - HCA Healthcare

$428.58 0,25% (12M)

P/E

13.82

0.71%

ROE

-213.15%

P/BV

-29.45